Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-23780-x.pdf
Reference40 articles.
1. Ashkenazi, A. et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104, 155–162 (1999).
2. Walczak, H. et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5, 157–163 (1999).
3. Sun, S. et al. Results on efficacy and safety of cancer treatment with or without tumor necrosis factor-related apoptosis-inducing ligand-related agents: A meta-analysis. Mol Clin Oncol 2, 440–448 (2014).
4. Lim, B. et al. Targeting TRAIL in the treatment of cancer: new developments. Expert Opin Ther Targets 19, 1171–1185 (2015).
5. Dimberg, L. Y. et al. On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene 32, 1341–1350 (2013).
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathway;Oncogene;2024-06-10
2. The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH;Advances in Biological Regulation;2024-05
3. Physicochemical Properties and Stability ofMOFs in Water Environments;Metal Organic Frameworks for Wastewater Contaminant Removal;2023-08-26
4. Fabricated design of hydrotalcite embedded lanthanum organic frameworks for defluoridation of water;Environmental Progress & Sustainable Energy;2023-04-10
5. Research Progress on the Anti-Tumor Mechanism and Reversal of Multidrug Resistance of Zuojin Pill and its Main Components, Evodiamine and Berberine;Natural Product Communications;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3